Home › Funds › UNIVERSITY OF CHICAGO › PYXS
UNIVERSITY OF CHICAGO position in PYXS
PYXIS ONCOLOGY INC · Health Care
UNIVERSITY OF CHICAGO reported holding 48,731 shares of PYXS (PYXIS ONCOLOGY INC) in its Q3 2026 13F filing — a position valued at US$114K, representing 0.03% of its reported portfolio and ranking #10 among its reported holdings. UNIVERSITY OF CHICAGO has disclosed PYXS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-14 · Source: SEC EDGAR Form 13F-HR
How UNIVERSITY OF CHICAGO's PYXS position evolved
UNIVERSITY OF CHICAGO first disclosed a stake in PYXS in Q3 2023 at 48,731 shares (US$97K). The position peaked in Q1 2024 at 48,731 shares, worth US$208K. Across 13 filings, UNIVERSITY OF CHICAGO held the position steady without any share-count change. The most recent filing (Q3 2026) shows 48,731 shares valued at US$114K.
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 48.73K | $96.97K | New |
| Q4 2023 | 48.73K | $87.72K | Hold |
| Q1 2024 | 48.73K | $207.59K | Hold |
| Q2 2024 | 48.73K | $161.30K | Hold |
| Q3 2024 | 48.73K | $178.84K | Hold |
| Q4 2024 | 48.73K | $76.02K | Hold |
| Q1 2025 | 48.73K | $47.75K | Hold |
| Q2 2025 | 48.73K | $53.60K | Hold |
| Q3 2025 | 48.73K | $108.18K | Hold |
| Q4 2025 | 48.73K | $56.04K | Hold |
| Q1 2026 | 48.73K | $71.15K | Hold |
| Q2 2026 | 48.73K | $146.68K | Hold |
| Q3 2026 | 48.73K | $113.54K | Hold |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About PYXS and 13F data
PYXS (PYXIS ONCOLOGY INC) is a Health Care company. 33 other funds we track also report a position in PYXS — the largest reported positions include GordonMD Global Investments LP (US$30.2M), PFIZER INC (US$20.1M), Laurion Capital Management LP (US$11.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding PYXS
- GordonMD Global Investments LP 10.02M sh · $30.17M · Q2 2026
- PFIZER INC 7.03M sh · $20.11M · Q3 2026
- Laurion Capital Management LP 4.99M sh · $11.63M · Q3 2026
- Palo Alto Investors LP 864.28K sh · $2.60M · Q2 2026
- Blue Owl Capital Holdings LP 1.00M sh · $2.33M · Q3 2026
- Stonepine Capital Management, LLC 689.00K sh · $1.61M · Q3 2026
- Atle Fund Management AB 663.77K sh · $1.55M · Q3 2026
- Decheng Capital LLC 326.81K sh · $761.47K · Q3 2026
- Monashee Investment Management LLC 229.31K sh · $534.29K · Q3 2026
More on UNIVERSITY OF CHICAGO
FAQ
How long has UNIVERSITY OF CHICAGO held PYXS?
UNIVERSITY OF CHICAGO has disclosed PYXS holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is UNIVERSITY OF CHICAGO's current position in PYXS?
As of Q3 2026, UNIVERSITY OF CHICAGO holds 48.73K shares of PYXS (PYXIS ONCOLOGY INC), valued at $113.54K, representing 0.03% of its reported portfolio and ranking #10.
Has UNIVERSITY OF CHICAGO been buying or selling PYXS?
In the latest 13F filing (Q3 2026), UNIVERSITY OF CHICAGO held unchanged its position in PYXS. The position peaked in Q1 2024 at 48.73K shares.
Which other funds hold PYXS?
Other major institutional holders of PYXS include GordonMD Global Investments LP, PFIZER INC, Laurion Capital Management LP, among 33 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.